408 related articles for article (PubMed ID: 19724043)
1. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
[TBL] [Abstract][Full Text] [Related]
2. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
3. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
[TBL] [Abstract][Full Text] [Related]
4. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
[TBL] [Abstract][Full Text] [Related]
5. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM
Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003
[TBL] [Abstract][Full Text] [Related]
6. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
Arzika AM; Mindo-Panusis D; Abdou A; Kadri B; Nassirou B; Maliki R; Alsoudi AF; Zhang T; Cotter SY; Lebas E; O'Brien KS; Callahan EK; Bailey RL; West SK; Goodhew EB; Martin DL; Arnold BF; Porco TC; Lietman TM; Keenan JD;
JAMA Netw Open; 2022 Aug; 5(8):e2228244. PubMed ID: 35997979
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
[TBL] [Abstract][Full Text] [Related]
8. Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
Keenan JD; Gebresillasie S; Stoller NE; Haile BA; Tadesse Z; Cotter SY; Ray KJ; Aiemjoy K; Porco TC; Callahan EK; Emerson PM; Lietman TM
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007442. PubMed ID: 31166952
[TBL] [Abstract][Full Text] [Related]
9. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
[TBL] [Abstract][Full Text] [Related]
10. Childhood mortality in a cohort treated with mass azithromycin for trachoma.
Keenan JD; Ayele B; Gebre T; Zerihun M; Zhou Z; House JI; Gaynor BD; Porco TC; Emerson PM; Lietman TM
Clin Infect Dis; 2011 Apr; 52(7):883-8. PubMed ID: 21427395
[TBL] [Abstract][Full Text] [Related]
11. Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.
Gebre T; Ayele B; Zerihun M; House JI; Stoller NE; Zhou Z; Ray KJ; Gaynor BD; Porco TC; Emerson PM; Lietman TM; Keenan JD
Am J Trop Med Hyg; 2011 Sep; 85(3):518-23. PubMed ID: 21896815
[TBL] [Abstract][Full Text] [Related]
12. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
[TBL] [Abstract][Full Text] [Related]
13. A rationale for continuing mass antibiotic distributions for trachoma.
Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
[TBL] [Abstract][Full Text] [Related]
14. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II).
Mahmud H; Haile BA; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Liu Z; Callahan EK; Cotter SY; Varnado NE; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Clin Infect Dis; 2023 Aug; 77(3):388-395. PubMed ID: 37021692
[TBL] [Abstract][Full Text] [Related]
15. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM
Am J Trop Med Hyg; 2018 Feb; 98(2):389-395. PubMed ID: 29260659
[TBL] [Abstract][Full Text] [Related]
17. A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children.
Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; Zhou Z; Bailey RL; Mabey DC; Porco TC; Keenan JD; Gaynor BD; West SK; Lietman TM
Clin Infect Dis; 2017 Mar; 64(6):743-750. PubMed ID: 27956455
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for ocular chlamydia after three mass azithromycin distributions.
Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
[TBL] [Abstract][Full Text] [Related]
19. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
[TBL] [Abstract][Full Text] [Related]
20. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
